|
|
Volumn 141, Issue 6, 2011, Pages 2268-2271
|
|
Treatment of chronic hepatitis delta: Mission impossible?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
FAMCICLOVIR;
GENOMIC RNA;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS DELTA ANTIGEN;
INTERFERON;
INTERLEUKIN 28B;
LAMIVUDINE;
PEGINTERFERON ALPHA2A;
VIRUS ENVELOPE PROTEIN;
ACUTE ON CHRONIC LIVER FAILURE;
CHRONIC LIVER DISEASE;
COMBINATION CHEMOTHERAPY;
DELTA AGENT HEPATITIS;
DNA POLYMORPHISM;
DRUG EFFICACY;
GENOTYPE;
HEPATITIS B VIRUS;
HEPATITIS DELTA VIRUS;
HIGH RISK POPULATION;
HUMAN;
INTRAVENOUS DRUG ABUSE;
LIVER CELL CARCINOMA;
LIVER FIBROSIS;
MONOTHERAPY;
MULTICENTER STUDY (TOPIC);
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SUPERINFECTION;
TREATMENT OUTCOME;
VACCINATION;
VIRUS CARRIER;
VIRUS NUCLEOCAPSID;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
|
|
EID: 81855209810
PISSN: 00165085
EISSN: 15280012
Source Type: Journal
DOI: 10.1053/j.gastro.2011.10.004 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
